1. Protalix BioTherapeutics, Inc.

    0 Comments Leave a Comment

    1-2 of 2
    1. Mentioned In 2 Articles

    2. Protalix BioTherapeutics Adds Two Accomplished Biopharmaceutical Executives to its Board of Directors

      Protalix BioTherapeutics Adds Two Accomplished Biopharmaceutical Executives to its Board of Directors
      CARMIEL,Israel,Dec. 19, 2019/PRNewswire/ -- Protalix BioTherapeutics, Inc.(NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellExplant cell-based protein expression system, today announced the appointment of Pol F. Boudes, MD, andGwen A. Melincoffto its Board of Directors...
      Read Full Article
    3. 1-2 of 2
  1. Categories

    1. BoardProspects Features:

      Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content